naltrexone has been researched along with Experimental Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blahoutová, V; Holán, V; Krulova, M; Wilczek, H; Zajícová, A | 1 |
| Ansary, B; Dehpour, Ar; Karaji, AG; Khansari, N | 1 |
| Blume, AJ; Fantozzi, R; Mullikin-Kilpatrick, D | 1 |
| Rosenkrantz, H | 1 |
| McLaughlin, PJ; Zagon, IS | 2 |
| Horn, PT; Mirkin, BL | 1 |
7 other study(ies) available for naltrexone and Experimental Neoplasms
| Article | Year |
|---|---|
Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice.
Topics: Animals; Cells, Cultured; Cytokines; Female; Fibrosarcoma; Heroin; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-12; Interleukin-2; Interleukin-4; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Narcotics; Neoplasms, Experimental; Nitric Oxide; Skin Transplantation; Spleen; Transplantation Immunology; Transplantation, Homologous | 2003 |
Detection of opioid receptors on murine lymphocytes by indirect immunofluorescence: mature normal and tumor bearing mice lymphocytes.
Topics: Animals; Avidin; Cell Line, Tumor; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Neoplasms, Experimental; Phycoerythrin; Receptors, Opioid; Spleen; T-Lymphocytes | 2005 |
Irreversible inactivation of the opiate receptors in the neuroblastoma x glioma hybrid NG108-15 by chlornaltrexamine.
Topics: Animals; Cyclic AMP; Enkephalin, Methionine; Enkephalins; Glioma; Hybrid Cells; Mice; Naloxone; Naltrexone; Neoplasms, Experimental; Neuroblastoma; Nitrogen Mustard Compounds; Prostaglandins E, Synthetic; Rats; Receptors, Opioid | 1981 |
Physiologic and morphologic changes and incidence of neoplasms in mice and rats fed naltrexone HCl for 24 months.
Topics: Administration, Oral; Animals; Behavior, Animal; Carcinogens; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Eating; Female; Growth; Lethal Dose 50; Male; Mice; Naloxone; Naltrexone; Neoplasms, Experimental; Rats; Rats, Inbred F344; Sex Factors; Species Specificity | 1984 |
Naltrexone modulates tumor response in mice with neuroblastoma.
Topics: Animals; Dose-Response Relationship, Drug; Endorphins; Male; Mice; Mice, Inbred Strains; Naloxone; Naltrexone; Neoplasm Transplantation; Neoplasms, Experimental; Neuroblastoma | 1983 |
Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors.
Topics: Animals; Cell Division; Cell Line; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Male; Mice; Naltrexone; Neoplasms, Experimental; Neuroblastoma; Receptors, Opioid | 1989 |
Lack of effect of the opioid antagonist, naltrexone, on the in situ growth of C-1300, N1E-115 and NS206 murine neuroblastoma tumor cell lines.
Topics: Animals; Body Weight; Chi-Square Distribution; Endorphins; Male; Mice; Mice, Inbred A; Naltrexone; Neoplasm Transplantation; Neoplasms, Experimental; Neuroblastoma; Receptors, Opioid; Tumor Cells, Cultured | 1989 |